Loading data for IDNA — first visit, this takes a few seconds.
iShares Genomics Immunology and Healthca... (IDNA)
NYSEArca: IDNA
· Real-Time Price · USD
39.77
-0.52 (-1.29%)
At close: Sep 04, 2026, 3:59 PM
The price, the headline numbers and the latest news, in one place.
iShares Genomics Immunology and Healthcare ETF (IDNA) Stock Price, Analysis & Data
-1.29% (1D)
| Bid | 0 |
| Market Cap | n/a |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| 0.00 | |
| n/a | |
| 25.56 | |
| n/a | |
| P/B (ttm) | 0.00 |
| P/S (ttm) | 0.00 |
| Earnings Date | n/a |
| Ask | 0 |
| Volume | 54,759 |
| Avg. Volume (20D) | 68,474 |
| Open | 40.15 |
| Previous Close | 40.29 |
| Day's Range | 39.60 - 40.15 |
| 52-Week Range | 22.33 - 41.49 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About IDNA
The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth...
Industry n/a
Sector n/a
IPO Date Jun 14, 2019
Employees n/a
Stock Exchange NYSEArca
Ticker Symbol IDNA
Financial Performance
In undefined, iShares Genomics Immunology and Healthcare ETF's revenue was n/a, an increase of undefined% compared to the previous year's n/a. Earnings were n/a, an increase of undefined%.
Financial StatementsEarnings Surprise
iShares Genomics Immunology and Healthcare ETF has released their quarterly earnings on Invalid Date:
- Revenue of n/a misses estimates by $0, with NaN% YoY growth.
- EPS of misses estimates by , with NaN% YoY growth.
Page 1 of 2